| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $120.5M | +8.7% |
| R&D Expense | $6.4M | +68.8% |
| SG&A Expense | $18.4M | +14.0% |
| Operating Income | $11.3M | +24.4% |
| Pre-tax Income | $11.0M | +37.3% |
| Income Tax | $199K | +24.4% |
| Net Income | $10.8M | +37.5% |
| EPS (Basic) | $0.10 | +135.7% |
| EPS (Diluted) | $0.10 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $15.1M | +17.9% |
| Inventory | $507K | -11.7% |
| Current Assets | $25.7M | +3.8% |
| Total Assets | $87.6M | +22.3% |
| Current Liabilities | $24.4M | +24.7% |
| Long-term Debt | $1.2M | +247.9% |
| Total Liabilities | $28.1M | +28.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $28.6M | +38.4% |
| Capital Expenditures | $4.8M | +181.6% |
| Investing Cash Flow | -$24.5M | -231.3% |
| Financing Cash Flow | -$5.6M | +50.2% |
| Free Cash Flow | $23.8M | +25.5% |
| +135.7% |
| Stockholders' Equity |
| $59.5M |
| +19.6% |